Control Bionics Ltd
ASX:CBL
Control Bionics Ltd
ASX:CBL
Price:
0.048 AUD
-4%
Market Closed
Updated:
May 18, 2024
Control Bionics Ltd
Research & Development
|
Control Bionics Ltd
Research & Development Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Control Bionics Ltd
ASX:CBL
|
Research & Development
-AU$231k
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Research & Development
-AU$236k
|
CAGR 3-Years
52%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Research & Development
-AU$3.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-57%
|
|
|
Cochlear Ltd
ASX:COH
|
Research & Development
-AU$269.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Research & Development
-AU$3.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Research & Development
-AU$2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is Control Bionics Ltd's Research & Development?
Research & Development
-231k
AUD
-231k
AUD
Based on the financial report for Jun 30, 2023, Control Bionics Ltd's Research & Development amounts to -231k AUD.
What is Control Bionics Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-24%
-24%
Over the last year, the Research & Development growth was 30%. The average annual Research & Development growth rates for Control Bionics Ltd have been -50% over the past three years , -24% over the past five years .
You don't have any saved screeners yet
